date,title,source
Oct-30-18,Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for,Zacks
Oct-31-18,Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7,PR Newswire
Nov-07-18,Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-07-18,Arena Pharmaceuticals: Don't Fight the Tape or Jim Cramer's Evaluation,TheStreet.com
Nov-08-18,Edited Transcript of ARNA earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-09-18,Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales,Zacks
Nov-13-18,Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions,PR Newswire
Nov-15-18,"Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today",Motley Fool
Nov-15-18,Why Arena Pharmaceuticals Stock Is Soaring Today,InvestorPlace
Nov-15-18,Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today,Motley Fool
Nov-15-18,4 Stocks To Watch As Investors Dump Tech; Head To Healthcare,ACCESSWIRE
Nov-15-18,"United Therapeutics to develop, sell Arena Pharma's hypertension treatment",Reuters
Nov-15-18,Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag,PR Newswire
Nov-16-18,"Arena (ARNA) Out-Licenses Rights to PAH Drug, Stock Up 22%",Zacks
Nov-16-18,Todays Research Reports on Stocks to Watch: Arena Pharmaceuticals and Sonoma Pharmaceuticals,ACCESSWIRE
Nov-20-18,Arena Pharmaceuticals to Participate in Upcoming Investor Conferences,PR Newswire
Nov-21-18,Opioid Alternatives Could Make Investors Major Gains,ACCESSWIRE
Nov-21-18,"Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal",Zacks
Nov-23-18,2 New Small Cap ETFs on the Block,Zacks
